Volker Straub

Active 1988–2025

234
Papers
27,817
Citations
99
h-index
217
i10-index

Citations

Citations per year for Volker Straub1988: 2 citations1993: 1 citations1994: 1 citations1995: 1 citations1996: 3 citations1997: 12 citations1998: 48 citations1999: 79 citations2000: 132 citations2001: 51 citations2002: 129 citations2003: 115 citations2004: 115 citations2005: 109 citations2006: 113 citations2007: 85 citations2008: 114 citations2009: 135 citations2010: 144 citations2011: 237 citations2012: 208 citations2013: 232 citations2014: 197 citations2015: 244 citations2016: 242 citations2017: 216 citations2018: 274 citations2019: 786 citations2020: 959 citations2021: 847 citations2022: 659 citations2023: 488 citations2024: 895 citations2025: 396 citations2026: 11 citations1989–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,399 citing papers, 22.8% of this breakdownUnited Kingdom: 1,172 citing papers, 11.1% of this breakdownItaly: 705 citing papers, 6.7% of this breakdownGermany: 623 citing papers, 5.9% of this breakdownFrance: 613 citing papers, 5.8% of this breakdownCanada: 463 citing papers, 4.4% of this breakdownNetherlands: 460 citing papers, 4.4% of this breakdownChina: 417 citing papers, 4% of this breakdownAustralia: 358 citing papers, 3.4% of this breakdownJapan: 318 citing papers, 3% of this breakdownSpain: 309 citing papers, 2.9% of this breakdownBelgium: 258 citing papers, 2.4% of this breakdown
0%22.8%Other 23.2%

Fields

  • Biochemistry, Genetics and Molecular Biology65.6%
  • Medicine25.5%
  • Neuroscience4.3%
  • Nursing1%
  • Computer Science0.7%
  • Immunology and Microbiology0.5%
  • Other2.4%

Topics

  • Muscle Physiology and Disorders14.4%
  • Neurogenetic and Muscular Disorders Research4.8%
  • Cardiomyopathy and Myosin Studies4.7%
  • Genetic Neurodegenerative Diseases3.3%
  • RNA Research and Splicing2.4%
  • Genomics and Rare Diseases2.3%
  • Other68.1%

Coauthors

All papers

Open in search
  1. The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard Roxburgh, Anna Łusakowska, Anna Kostera‐Pruszczyk, Janusz Zimowski, Rosário Santos, Elena Neagu, Svetlana Artemieva, Vedrana Milić Rašić, Dina Vojinović, Manuel Posada de la Paz, Clemens Bloetzer, P.Y. Jeannet, Franziska Joncourt, Jordi Díaz‐Manera, Eduard Gallardo, Ayşen Karaduman, Haluk Topaloğlu, Rasha El Sherif, Angela Stringer, Andriy Shatillo, Ann Martin, Holly L. Peay, M. Bellgard, Janbernd Kirschner, Kevin M. Flanigan, Volker Straub, Kate Bushby, Jan J.G.M. Verschuuren, Annemieke Aartsma‐Rus, Christophe Béroud, Hanns Lochmüller - Human Mutation 2015 cited by 744

  2. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michaela Foà, Valeria Parente, L. Buscemi, Fabian Dal Farra, Olga Schneider, Anovick Jonas, A.C. Defeldre, Emanuela Pagliano, Riccardo Zanin, Maria Teresa Arnoldi, Veronica Schembri, M. Del Sole, Anna Mandelli, Maria Carmela Pera, Laura Antonaci, Giorgia Coratti, Rita De Sanctis, Marika Pane, Mariacristina Scoto, Katie Groves, Lisa Edel, François Abel, H. van Ruiten, R. Muni Lofra, E. T. Thompson - The Lancet Neurology 2021 cited by 256

  3. Global synergistic actions to improve brain health for human development

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandra Heumber Perry, Ericka L. Fink, Peer Baneke, Anne Helme, Joanna Laurson-Doube, Marco T. Medina, Juan David Roa, Birgit Högl, Allan O’Bryan, Claudia Trenkwalder, Jo M. Wilmshurst, Rufus Akinyemi, Joseph Yaria, David C. Good, Volker Hoemberg, Paul Boon, Samuel Wiebe, J. Helen Cross, Magali Haas, Inez Jabalpurwala, Marijeta Mojasevic, Mónica Di Luca, Paola Barbarino, Stéphanie Clarke, Sameer M. Zuberi, Paul Olowoyo, Ayomide Owolabi, Nelson M. Oyesiku, Pia C. Sundgren, Bo Norrving, Surjo R. Soekadar, Pieter A. van Doorn, Richard Lewis, Tom Solomon, Franco Servadei - Nature Reviews Neurology 2023 cited by 113

  4. Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy

    Authors: , , , , , , , , , , , , , , , - Neurology 2020 cited by 325

  5. The Human Phenotype Ontology in 2017

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gholson J. Lyon, Soichi Ogishima, Annie Olry, Willem H. Ouwehand, Nikolas Pontikos, Ana Rath, Franz Schaefer, Richard H. Scott, Michael Segal, Panagiotis I. Sergouniotis, Richard Sever, Cynthia L. Smith, Volker Straub, Rachel Thompson, Catherine Turner, Ernest Turro, Marijcke W. M. Veltman, Tom Vulliamy, Jing Yu, Julie von Ziegenweidt, Andreas Zankl, Stephan Züchner, Tomasz Zemojtel, Julius O. B. Jacobsen, Tudor Groza, Damian Smedley, Christopher J. Mungall, Melissa A. Haendel, Peter N. Robinson - Nucleic Acids Research, Nucleic Acids Res. 2016 cited by 801

  6. Genome Sequencing for Diagnosing Rare Diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Denny Popp, Tilman Polster, Konrad Platzer, Eric A. Pierce, Emily Place, Sander Pajusalu, Lynn Pais, Katrin Õunap, Ikeoluwa Osei‐Owusu, Henry Opperman, Volkan Okur, Kaisa Teele Oja, Melanie O’Leary, Emily O’Heir, Chantal F. Morel, Andreas Merkenschlager, Rhett G. Marchant, Brian Mangilog, Jill A. Madden, Daniel G. MacArthur, Alysia Kern Lovgren, Jordan Lerner‐Ellis, Jasmine Lin, Nigel G. Laing, Friedhelm Hildebrandt, Julia Hentschel, Emily Groopman, Julia K. Goodrich, Joseph G. Gleeson, Roula Ghaoui, Casie A. Genetti, Janina Gburek‐Augustat, Hanna T. Gazda, Vijay Ganesh, Mythily Ganapathi, Lyndon Gallacher, Jack Fu, Emily Evangelista, Eleina England, Sandra Donkervoort, Stephanie DiTroia, Sandra T. Cooper, Wendy K. Chung, John Christodoulou, Katherine R. Chao, Liam D. Cato, Kinga M. Bujakowska, Samantha J. Bryen, Harrison Brand, Carsten G. Bönnemann, Alan H. Beggs, Samantha Baxter, Tobias Bartolomaeus, Pankaj B. Agrawal, Michael E. Talkowski, Christina Austin‐Tse, Rami Abou Jamra, Heidi L. Rehm, Anne O’Donnell‐Luria - New England Journal of Medicine 2024 cited by 184

  7. Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Migvis Monduy, Yoram Nevo, Juan J. Vílchez, Andres Nascimento-Osorio, E. Niks, Imelda J. M. de Groot, Marina Katsalouli, M. James, Johannes van den Anker, Jesse M. Damsker, Alexandra Ahmet, Leanne M. Ward, Mark Jaros, Phil Shale, Utkarsh J. Dang, Eric P. Hoffman - JAMA Neurology 2022 cited by 130

  8. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthias Boentert, Gérson Carvalho, Nizar Chahin, Joel Charrow, Patrick Deegan, Hacer Durmuş Tekçe, Fanny Duval, Angela Genge, Ludwig Gutmann, Robert D. Henderson, Julia B. Hennermann, Tarekegn Hiwot, Derralynn Hughes, Amel Karaa, Chafic Karam, Alexandra Kautzky‐Willer, Hirofumi Komaki, Pascal Laforêt, Nicola Longo, Vĕra Malinová, Ricardo Maré, Clarisa Maxit, Eugen Mengel, Maurizio Moggio, Mária Judit Molnár, Tiziana Mongini, Aleksandra Nadaj‐Pakleza, A. Nascimento Osorio, Jean‐Baptiste Noury, Acary Souza Bullé Oliveira, Yeşim Parman, Loren Peña, Gauthier Remiche, Monica Sciacco, Perry B. Shieh, Cheryl J. Smith, Thomas M. Stulnig, Frédéric Taithe, Céline Tard, Mark A. Tarnopolsky, Matthias Vorgerd, Chester B. Whitley, Peter Young, Jorge Alonso‐Pérez, Patricia Altemus, Anne-Catherine Aubé-Nathier, Jennifer Avelar, Carrie Bailey, Can Ebru Bekircan‐Kurt, Jenny Billy, Silvia Boschi, Kathryn E. Brown, Laura Carrera‐García, Lauren Chase, Hamilton Cirne, Loïc Danjoux, Jean‐Baptiste Davion, Stephanie DeArmey, E. Yu. Fedotova, Eve Gandolfo, Zoltán Grosz, Dewi Guellec, Anne-Katrin Guettsches, Michela Guglieri, Erin Hatcher, Sina Helms, Miriam Hufgard‐Leitner, S. A. Klyushnikov, Jacqui Langton, Lenka Linková and 35 more - The Lancet Neurology 2021 cited by 184

  9. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Florian P. Thomas, Katherine R. Chao, Chamindra G. Konersman, Megan T. Cho, Tracy Brandt, Volker Straub, Anne M. Connolly, Ulrike Schara, Andreas Roos, Mark A. Tarnopolsky, Ahmet Höke, Robert H. Brown, Chia‐Hsueh Lee, Thorsten Hornemann, Teresa Dunn, Carsten G. Bönnemann - Nature Medicine 2021 cited by 152

  10. Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Birte Zurek, Kornelia Ellwanger, German Demidov, Marc Sturm, Christoph Keßler, Melanie Wayand, Carlo Wilke, Andreas Traschütz, Lüdger Schöls, Holger Hengel, Peter Heutink, Han G. Brunner, Hans Scheffer, Wouter Steyaert, Karolis Sablauskas, Richarda M. de Voer, Erik-Jan Kamsteeg, Bart van de Warrenburg, Nienke van Os, Iris te Paske, Erik Janssen, Elke de Boer, Marloes Steehouwer, Burcu Yaldız, Tjitske Kleefstra, Colin Veal, Spencer Gibson, Marc Wadsley, Mehdi Mehtarizadeh, Umar Riaz, Greg Warren, Farid Yavari Dizjikan, Thomas Shorter, Volker Straub, C. Marini Bettolo, Sabine Specht, Jill Clayton‐Smith, Siddharth Banka, Elizabeth Alexander, Adam Jackson, Laurence Faivre, Christel Thauvin, Antonio Vitobello, Anne‐Sophie Denommé‐Pichon, Yannis Duffourd, Émilie Tisserant, Ange‐Line Bruel, Christine Peyron, Aurore Pélissier, Sergi Beltrán, Marta Gut, Steven Laurie, Davide Piscia, Leslie Matalonga, Anastasios Papakonstantinou, Gemma Bullich, Alberto Corvò, Carles García, Marcos Fernandez-Callejo, Carles Hernandéz-Ferrer, Daniel Picó, Ida Paramonov, Hanns Lochmüller, Gulcin Gumus, Virginie Bros‐Facer, Marc Hanauer, Annie Olry, David Lagorce, Svitlana Havrylenko, Katia Izem and 123 more - European Journal of Human Genetics 2021 cited by 103

  11. Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nancy L. Kuntz, Adnan Manzur, Basil T. Darras, Peter B. Kang, Leslie Morrison, Monika Krzesniak‐Swinarska, Jean K. Mah, Tiziana Mongini, Federica Ricci, Maja von der Hagen, Richard S. Finkel, Kathleen O’Reardon, Matthew Wicklund, Ashutosh Kumar, Craig M. McDonald, Jay J. Han, Nanette C. Joyce, Erik Henricson, Ulrike Schara‐Schmidt, Andrea Gangfuß, Ekkehard Wilichowski, Richard J. Barohn, Jeffrey Statland, Craig Campbell, Giuseppe Vita, Gian Luca Vita, James F. Howard, Imelda Hughes, Hugh J. McMillan, Elena Pegoraro, Luca Bello, W. Bryan Burnette, Mathula Thangarajh, Taeun Chang - JAMA 2022 cited by 123

  12. Long-Term Safety and Efficacy Data of Golodirsen in Ambulatory Patients with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A First-in-human, Multicenter, Two-Part, Open-Label, Phase 1/2 Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diane E. Frank, Frederick J. Schnell - Nucleic Acid Therapeutics 2021 cited by 126

  13. Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giovanni Baranello, S. Robb, Rosaline C. M. Quinlivan, Anna Sárközy, Pinki Munot, Marion Main, Lianne Abbot, Volker Straub, Michela Guglieri, Chiara Bertolli, Anna Mayhew, Robert Muni‐Lofra, M. James, Jassi Sodhi, Deepak Parasuraman, Z. Alhaswani, Heather McMurchie, Rosanna Rabb, Anne‐Marie Childs, Karen Pysden, Lindsey Pallant, Tiffany Small, Stefan Spinty, R Madhu, Alison Shillington, Sarah Gregson, Elizabeth Wraige, Heinz Jungbluth, Vasantha Gowda, Jennie Sheehan, Imelda Hughes, Sinead Warner, Emily Davies, Tracey Willis, R. Kulshrestha, N. Emery, Kate Strachan, Min Ong, Kay White, Kate Skone, Frances Gibbon, Bethan Parsons, Anirban Majumdar, Kayal Vijaykumar, Faye Mason, Claire Frimpong-Ansah, Karen Naismith, Julie Burslem, Iain Horrocks, Marina Di Marco, Sarah M. Brown, Sarah Williamson, Kirstie Spencer, Gabby Chow, Christian de Goede, Andrea Selley, Neil Thomas, Marjorie Illingworth, Michelle Greary, Jenni Palmer, Cathy White, Kate Greenfield, Grainne Nic Fhirleinn, Melanie Douglas, Sandya Tiraputhi, Nahin Hussain, Yvonne Julien, Gautam Ambegaonkar, Deepa Krishnakumar, Jacqui Taylor and 43 more - JAMA Network Open 2022 cited by 88

  14. Revised upper limb module for spinal muscular atrophy: 12 month changes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Muscle & Nerve 2019 cited by 150

  15. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet 2011 cited by 862

  16. Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Annie M. Sbrocchi, Kathryn Selby, Migvis Monduy, Yoram Nevo, Juan J. Vílchez, Andres Nascimento-Osorio, E. Niks, Imelda J. M. de Groot, Marina Katsalouli, John N. van den Anker, Leanne M. Ward, Mika Leinonen, Andrea L. D'Alessandro, Eric P. Hoffman - Neurology 2024 cited by 70

  17. Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennie Sheehan, Robert C. Spahr, Imelda Hughes, Eric D. Bateman, Christopher J Cammiss, Tracey Willis, Lesley J. Groves, N. Emery, Peter Baxter, M. Senior, Louise Hartley, Bruce Parsons, Anirban Majumdar, Lucy Jenkins, Karen Naismith, A. Keddie, Iain Horrocks, Marina Di Marco, Gabby Chow, Aisha Miah, Christian de Goede, Nick Thomas, Michelle Geary, Jenni Palmer, Charles I. White, Kate Greenfield, E. Scott - Journal of Neurology Neurosurgery & Psychiatry 2012 cited by 260

  18. 229th ENMC international workshop: Limb girdle muscular dystrophies – Nomenclature and reformed classification Naarden, the Netherlands, 17–19 March 2017

    Authors: , , , , , , , , , , , , , , , , , , , , , - Neuromuscular Disorders 2018 cited by 384

  19. Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gérson Carvalho, Nizar Chahin, Joel Charrow, Patrick Deegan, Hacer Durmuş Tekçe, Fanny Duval, Angela Genge, Ludwig Gutmann, Robert D. Henderson, Julia B. Hennermann, Tarekegn Hiwot, Derralynn Hughes, Amel Karaa, Chafic Karam, Alexandra Kautzky‐Willer, Hirofumi Komaki, Pascal Laforêt, Nicola Longo, Vĕra Malinová, Ricardo Maré, Clarisa Maxit, Eugen Mengel, Maurizio Moggio, Mária Judit Molnár, Tiziana Mongini, Aleksandra Nadaj‐Pakleza, A. Nascimento Osorio, Jean‐Baptiste Noury, Acary Souza Bullé Oliveira, Yeşim Parman, Loren Peña, Gauthier Remiche, Monica Sciacco, Perry B. Shieh, Cheryl J. Smith, Thomas M. Stulnig, Frédéric Taithe, Céline Tard, Mark A. Tarnopolsky, Matthias Vorgerd, Chester B. Whitley, Peter Young, Jorge Alonso‐Pérez, Patricia Altemus, Anne-Catherine Aubé-Nathier, Jennifer Avelar, Carrie Bailey, Can Ebru Bekircan‐Kurt, Jenny Billy, Silvia Boschi, Kathryn E. Brown, Laura Carrera‐García, Lauren Chase, Hamilton Cirne, Loïc Danjoux, Jean‐Baptiste Davion, Stephanie DeArmey, E. Yu. Fedotova, Eve Gandolfo, Zoltán Grosz, Dewi Guellec, Anne-Katrin Guettsches, Michela Guglieri, Erin Hatcher, Sina Helms, Miriam Hufgard‐Leitner, S. A. Klyushnikov, Jacqui Langton, Lenka Linková, Nicolas Mavroudakis and 34 more - JAMA Neurology 2023 cited by 55

  20. A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2008 cited by 468

  21. Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2022 cited by 46

  22. The burden of Duchenne muscular dystrophy

    Authors: , , , , , , , - Neurology 2014 cited by 228

  23. Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoGAA) in treatment-naïve and alglucosidase alfa-treated patients with late-onset Pompe disease: A phase 1, open-label, multicenter, multinational, ascending dose study

    Authors: , , , , , , , , , , , , , , , , , , , , - Neuromuscular Disorders 2018 cited by 90

  24. Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Farhad Bayat, Filippo Buccella, Alessandra Ferlini, En Kimura, J.C. van den Bergen, Miriam Rodrigues, Richard Roxburgh, Anna Łusakowska, Anna Kostera‐Pruszczyk, Rosário Santos, Elena Neagu, Svetlana Artemieva, Vedrana Milić Rašić, Dina Vojinović, Manuel Posada de la Paz, Clemens Bloetzer, Andrea Klein, Jordi Díaz‐Manera, Eduard Gallardo, Aynur Ayşe Karaduman, Tunca Oznur, Haluk Topaloğlu, Rasha El Sherif, Angela Stringer, Andriy Shatillo, Ann Martin, Holly L. Peay, Janbernd Kirschner, Kevin M. Flanigan, Volker Straub, Kate Bushby, Christophe Béroud, Jan J.G.M. Verschuuren, Hanns Lochmüller - Journal of Neuromuscular Diseases 2017 cited by 182